Arzneiwerk AG VIDA, formerly known as TELES Aktiengesellschaft, is a German company that has pivoted from its origins in the telecommunications sector to the pharmaceutical industry. The company is now a financial holding company with a focus on the "specialty pharma" segment in Germany and Europe.
What the Company Does
Arzneiwerk AG VIDA operates within the pharmaceutical segment, concentrating on the supply of newly developed or rare, high-priced drugs. It focuses on several key therapeutic areas, including:
Oncology
Neurology
Autoimmune diseases
Ophthalmology
Hemophilia
Infectious diseases
The company's business model is centered on combining pharmaceutical supply with digitalization and process optimization along the pharmaceutical supply chains. This includes the management of large data volumes within the pharmaceutical industry to improve efficiency.
Products and Services
Arzneiwerk AG VIDA, through its subsidiary Euro RX Arzneimittel, supplies a range of specialty drugs. The company's services are built around guaranteeing optimal pharmaceutical care for patients and providing pharmacies in Europe with integrated solutions for stable and reliable delivery. While specific product names are not prominently disclosed by the parent company, the focus is on the logistics and distribution of specialized medications for chronic, complex, or rare diseases. The company's services are rooted in a digitalized supply chain, which is a key component of its business strategy.
Please note: This information is generated by AI. For legal use, verify with company sources.
